McKenna Bryon J, Cook Jeremy, Cook Emily A, Crafton Jordan, Knabel Matthew, Swenson Eric, Miner Samantha, Manning Elena, Basile Philip
Fellow, Orthopedic Foot and Ankle Center, Worthington, OH.
Assistant Professor in Surgery, Department of Surgery, Harvard Medical School, Boston, MA; Director of Research and Quality Assurance, Division of Podiatric Surgery, Department of Surgery, Mount Auburn Hospital, Cambridge, MA.
J Foot Ankle Surg. 2020 Sep-Oct;59(5):1040-1048. doi: 10.1053/j.jfas.2019.10.011. Epub 2020 Jun 26.
The gold standard for management of end-stage ankle arthritis was previously ankle arthrodesis; however, improvements in total ankle replacements are making this a more viable treatment option. The primary aim of this meta-analysis was to evaluate the survivorship of total ankle replacement implants currently in use. An extensive search strategy initially captured 20,842 citations that were evaluated for relevance. Abstract screening produced 97 articles to be read in entirety, of which 10 articles studying 1963 implants met all prospective inclusion criteria for analysis. Overall survivorship of all implants was 93.0% (95% confidence interval, 85.2-96.9) using a random effect model. There was significant heterogeneity between the studies (Q = 131.504). Meta-regression identified an inverse relationship between survivorship and study follow-up duration (p < .0001). Furthermore, age (p = .36) and implant type (fixed-bearing [95.6%, 95% confidence interval, 85.9-98.7] versus mobile-bearing ]89.4%, 95% confidence interval, 79.6%-94.8%]) did not have a statistically significant impact on survivorship, p = .213. However, patients with higher preoperative functional scores had improved survivorship (p = .001). Complications were inconsistently reported with varied definitions. In order of reported frequency, complications were classified into technical error (28.15%), subsidence (16.89%), implant failure (13.28%), aseptic loosening (6.3%), intraoperative fracture (5.67%), wound problems (4.3%), deep infection (1%), and postoperative fracture (0.0001%). Overall study quality was low, with only 10% being prospective and 90% from nonregistry data. The results from this meta-analysis revealed a promising overall survivorship of current implants in use for total ankle replacement; however higher quality studies with standardized outcomes measures are needed.
终末期踝关节关节炎的管理金标准曾是踝关节融合术;然而,全踝关节置换术的改进使其成为一种更可行的治疗选择。本荟萃分析的主要目的是评估目前使用的全踝关节置换植入物的生存率。广泛的检索策略最初获取了20842条被评估相关性的文献。摘要筛选产生了97篇需全文阅读的文章,其中10篇研究1963个植入物的文章符合所有纳入分析的前瞻性标准。使用随机效应模型,所有植入物的总体生存率为93.0%(95%置信区间,85.2 - 96.9)。研究之间存在显著异质性(Q = 131.504)。Meta回归确定生存率与研究随访时间之间存在负相关(p <.0001)。此外,年龄(p =.36)和植入物类型(固定承重[95.6%,95%置信区间,85.9 - 98.7]与活动承重[89.4%,95%置信区间,79.6% - 94.8%])对生存率没有统计学上的显著影响,p =.213。然而,术前功能评分较高的患者生存率更高(p =.001)。并发症的报告不一致,定义各异。按报告频率排序,并发症分为技术错误(28.15%)、下沉(16.89%)、植入物失败(13.28%)、无菌性松动(6.3%)、术中骨折(5.67%)、伤口问题(4.3%)、深部感染(1%)和术后骨折(0.0001%)。总体研究质量较低,只有10%为前瞻性研究,90%来自非注册数据。本荟萃分析的结果显示,目前用于全踝关节置换的植入物总体生存率前景良好;然而,需要更高质量的研究和标准化的结果测量方法。